Company Filing History:
Years Active: 2014-2018
Title: Elina Zorde Khvalevsky: Innovator in RNA Interference Technologies
Introduction
Elina Zorde Khvalevsky is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of RNA interference (RNAi) technologies. With a total of six patents to her name, her work focuses on innovative methods for treating cancer.
Latest Patents
Among her latest patents is a groundbreaking invention related to RNA interference compositions targeting heat shock protein 90 (HSP90). This patent describes RNAi compositions that specifically target the expression of HSP90 in a subject. Additionally, it includes polymeric delivery devices designed to provide these RNAi compositions, along with methods for treating cancer using these innovative solutions. Another notable patent involves methods and compositions for treating prostate cancer, which emphasize regional and prolonged release of nucleotide-based RNAi agents.
Career Highlights
Elina has established herself as a key figure in her field through her innovative research and development efforts. Her work at Silenseed Ltd. has positioned her at the forefront of cancer treatment technologies. She has demonstrated a commitment to advancing medical science through her inventions.
Collaborations
Elina collaborates with talented individuals such as Amotz Shemi and Rachel Malka Gabai, contributing to a dynamic research environment that fosters innovation.
Conclusion
Elina Zorde Khvalevsky's contributions to RNA interference technologies represent a significant advancement in cancer treatment. Her innovative patents and collaborative efforts continue to shape the future of biotechnology.